Latest Period
Q1 2026
Security Snapshot
Solid Biosciences Inc. - Common Stock $0.001 par value per share (SLDB) Institutional Ownership
CUSIP: 83422E105
13F Institutional Holders and Ownership History from Q1 2018 to Q1 2026
Institutions Reporting
8
Shares (Excl. Options)
6,054
Price
$7.20
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Type / Class
- Equity / Common Stock $0.001 par value per share
- Symbol
- SLDB on Nasdaq
- Shares outstanding
- 100,767,588
- Price per share
- $7.20
- All holders as of 31 Mar 2026
- Q1 2026
- Total 13F shares
- 6,054
- Total reported value
- $43,989
- % of total 13F portfolios
- 0%
- Share change
- +4,684
- Value change
- +$34,058
- Number of holders
- 8
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Key facts
- SLDB - Solid Biosciences Inc. - Common Stock $0.001 par value per share is tracked under CUSIP 83422E105.
- 8 institutions reported positions in Q1 2026.
- 3 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 5 to 8 between Q4 2025 and Q1 2026.
- Reported value moved from $7,726 to $43,989.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC Evidence
Latest holder context comes from 8 institutions filings for Q1 2026.
Security key
83422E105
Latest holder period
Q1 2026
13F holders
8
13D/G owners
3
CIK / CUSIP context first
Open Q1 2026 holders
SLDB full holder history
Solid Biosciences Inc. SEC filings
Solid Biosciences Inc. company facts
Solid Biosciences Inc. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 83422E105:
Significant Owners of Solid Biosciences Inc. - Common Stock $0.001 par value per share (SLDB) based on Schedule 13D/G filings
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Invus Global Management, LLC | 10% | 10,066,682 | Raymond Debbane | 31 Mar 2026 | ||||
| RA CAPITAL MANAGEMENT, L.P. | 9.9% | 0% | +$7,466,867 | 9,313,756 | +17% | RA Capital Management, L.P. | 13 Mar 2026 | |
| BlackRock, Inc. | 4.7% | 4,578,650 | BlackRock, Inc. | 31 Mar 2026 |
As of 31 Mar 2026, 8 institutional investors reported holding 6,054 shares of Solid Biosciences Inc. - Common Stock $0.001 par value per share (SLDB). This represents 0.01% of the company’s total 100,767,588 outstanding shares.
Institutional Holders of Solid Biosciences Inc. - Common Stock $0.001 par value per share (SLDB) across Reporting Periods
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q1 | 6,054 | $43,989 | +$34,058 | $7.20 | 8 |
| 2025 Q4 | 1,370 | $7,726 | -$62,723 | $5.64 | 5 |
| 2025 Q3 | 12,230 | $75,459 | +$70,936 | $6.17 | 4 |
| 2025 Q2 | 733 | $3,569 | +$1,352 | $4.87 | 3 |
| 2025 Q1 | 478 | $1,769 | +$1,743 | $3.71 | 3 |
| 2024 Q4 | 7 | $28 | $4.00 | 1 | |
| 2024 Q3 | 7 | $49 | $7.00 | 1 | |
| 2024 Q2 | 7 | $40 | +$6 | $5.71 | 1 |
| 2024 Q1 | 6 | $80 | $13.33 | 1 | |
| 2023 Q4 | 6 | $37 | $6.17 | 1 | |
| 2023 Q3 | 6 | $15 | -$346 | $2.50 | 1 |
| 2023 Q2 | 72 | $377 | $5.20 | 2 | |
| 2023 Q1 | 72 | $341 | -$57,791 | $4.70 | 2 |
| 2022 Q4 | 10,806 | $58,136 | -$29,139,216 | $5.36 | 2 |
| 2022 Q3 | 62,916,116 | $29,199,793 | +$794,183 | $0.47 | 49 |
| 2022 Q2 | 64,213,719 | $39,529,533 | -$5,527,398 | $0.62 | 56 |
| 2022 Q1 | 69,295,383 | $83,158,688 | -$8,045,281 | $1.20 | 73 |
| 2021 Q4 | 75,541,107 | $132,178,834 | -$5,128,947 | $1.75 | 78 |
| 2021 Q3 | 76,975,796 | $184,313,421 | -$8,372,053 | $2.39 | 86 |
| 2021 Q2 | 80,038,410 | $292,936,775 | +$60,718 | $3.66 | 86 |
| 2021 Q1 | 79,131,292 | $437,590,934 | +$134,289,421 | $5.53 | 103 |
| 2020 Q4 | 54,604,305 | $413,863,843 | +$230,271,907 | $7.58 | 75 |
| 2020 Q3 | 25,431,070 | $51,626,219 | -$3,132,877 | $2.03 | 55 |
| 2020 Q2 | 26,709,659 | $78,256,131 | +$21,247,711 | $2.93 | 65 |
| 2020 Q1 | 19,636,888 | $46,931,304 | -$1,346,208 | $2.39 | 70 |
| 2019 Q4 | 19,881,433 | $88,468,790 | -$123,259,144 | $4.45 | 67 |
| 2019 Q3 | 32,117,446 | $332,091,673 | +$95,994,970 | $10.34 | 69 |
| 2019 Q2 | 18,570,664 | $106,695,745 | +$20,118,478 | $5.75 | 71 |
| 2019 Q1 | 17,113,127 | $157,446,313 | -$213,488,146 | $9.20 | 74 |
| 2018 Q4 | 24,190,736 | $648,312,427 | +$128,327,742 | $26.80 | 74 |
| 2018 Q3 | 18,605,082 | $877,772,812 | +$64,671,762 | $47.18 | 76 |
| 2018 Q2 | 15,341,932 | $545,311,685 | +$93,312,873 | $35.63 | 63 |
| 2018 Q1 | 15,597,572 | $116,521,712 | +$116,521,712 | $7.50 | 55 |